Narcotic analgesics, their detection and pain measurement in the horse: a review.

The research focuses on the effectiveness of narcotic analgesics (pain relievers) used in equine medicine and their side effects, with particular emphasis on those interacting with mu and kappa opioid receptors.

Narcotic Analgesics and Opiate Receptors

• This study scrutinizes the relationship between narcotic analgesics and opiate receptors. It highlights morphine and ethylketazocine specifically, which interact with mu and kappa receptors respectively.
• Opiate receptors in mammals are proteins that respond to opioids (naturally occurring substances found in opium poppy plants which include morphine and codeine), synthesizing their desired effect.
• At least five types of opiate receptors have been identified, but this study focuses mainly on mu and kappa receptor types.

Effects of Mu and Kappa Agonist Analgesics

• The study reveals that narcotic analgesics interacting with mu receptors produce locomotor and autonomic stimulation, effects that facilitate movement or control body functions, but, importantly, they may not relieve pain effectively. This makes these drugs inadequate for use as pain-killers in equine medicine.
• The research also explores the use of kappa agonists, which appear to be more satisfactory for equine pain relief. Using a pure kappa agonist, U-50, 488H, resulted in effective analgesia (pain relief) with little or no locomotor or autonomic side effects. This suggests that kappa agonists might be better pain relievers for clinical use in horses.
• The study also mentions the controversial use of mu agonist analgesics in racehorses. While these drugs can potentially produce positive effects, like an enhanced running response and central nervous system stimulation, their usage is considered illegal due to these performance-enhancing qualities.

Detection and Regulation of Narcotic Analgesics

• The paper delves into the detection and regulation of narcotic analgesics, acknowledging that most can be identified via high-performance thin-layer chromatographic screening.
• However, for specific drugs like the fentanyls and small doses of etorphine, effective screening requires the use of immunoassay, a biochemistry test that measures the presence or concentration of molecules.